Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Enterprise Value (2023 - 2025)

Mangoceuticals' Enterprise Value history spans 3 years, with the latest figure at -$499962.0 for Q3 2025.

  • For Q3 2025, Enterprise Value fell 2712.09% year-over-year to -$499962.0; the TTM value through Sep 2025 reached -$499962.0, down 2712.09%, while the annual FY2024 figure was -$18023.0, 6.38% down from the prior year.
  • Enterprise Value for Q3 2025 was -$499962.0 at Mangoceuticals, down from -$119142.0 in the prior quarter.
  • Across five years, Enterprise Value topped out at -$36.0 in Q1 2024 and bottomed at -$3.8 million in Q1 2023.
  • The 3-year median for Enterprise Value is -$18072.0 (2024), against an average of -$571834.4.
  • The largest annual shift saw Enterprise Value skyrocketed 100.0% in 2024 before it plummeted 50236.11% in 2025.
  • A 3-year view of Enterprise Value shows it stood at -$16942.0 in 2023, then decreased by 6.38% to -$18023.0 in 2024, then crashed by 2674.02% to -$499962.0 in 2025.
  • Per Business Quant, the three most recent readings for MGRX's Enterprise Value are -$499962.0 (Q3 2025), -$119142.0 (Q2 2025), and -$18121.0 (Q1 2025).